TFAM and Alzheimer disease: Previous studies have shown that the levels of PGC-1α, NRF1, and TFAM in the hippocampus of AD patients and animal models are significantly reduced, indicating impaired mitochondrial biogenesis (Sheng et al., 2012; Singulani et al., 2020).